Matches in Wikidata for { <http://www.wikidata.org/entity/Q64217297> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q64217297 description "assaig clínic" @default.
- Q64217297 description "clinical trial" @default.
- Q64217297 description "clinical trial" @default.
- Q64217297 description "clinical trial" @default.
- Q64217297 description "clinical trial" @default.
- Q64217297 description "ensaio clínico" @default.
- Q64217297 description "ensayo clínico" @default.
- Q64217297 description "ensayu clínicu" @default.
- Q64217297 description "essai clinique" @default.
- Q64217297 description "klinisch onderzoek" @default.
- Q64217297 description "клінічне випробування" @default.
- Q64217297 name "A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations" @default.
- Q64217297 type Item @default.
- Q64217297 label "A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations" @default.
- Q64217297 prefLabel "A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations" @default.
- Q64217297 P1132 Q64217297-249122E7-235E-45BE-AEC0-704AB0999480 @default.
- Q64217297 P1476 Q64217297-6567CE14-5C4B-4722-9EBD-B67F0264EAC0 @default.
- Q64217297 P17 Q64217297-02B571F9-CC5A-4F3B-B5C8-D17A647A3CD8 @default.
- Q64217297 P17 Q64217297-0A042E19-EDB3-46D7-AE6F-C2F1744C1358 @default.
- Q64217297 P17 Q64217297-0D1D724F-63B1-4EBE-9F21-A2E93C9639F6 @default.
- Q64217297 P17 Q64217297-16C6771A-7934-4647-8D42-4C9CC6B7239E @default.
- Q64217297 P17 Q64217297-1755F2BA-C90A-42AC-8A82-A01AAD43C4B8 @default.
- Q64217297 P17 Q64217297-1A82C755-3F6C-4612-98CC-0E69BD903752 @default.
- Q64217297 P17 Q64217297-20C3C438-D950-478E-861A-062F0CF11994 @default.
- Q64217297 P17 Q64217297-349D37BE-E32E-4C9C-9CB1-D276C3430D7F @default.
- Q64217297 P17 Q64217297-57D65AEF-F7CB-496C-973B-23E4F66A3B06 @default.
- Q64217297 P17 Q64217297-750DF7D9-449E-4D49-8044-EAF1DE7FDCDA @default.
- Q64217297 P17 Q64217297-783BD370-0446-4D2E-91EB-127F98F37D3D @default.
- Q64217297 P17 Q64217297-789A2FF2-0CB0-4EB7-A050-710DDB82D2C4 @default.
- Q64217297 P17 Q64217297-853F65EF-FC51-4BB1-8204-86CB3FF59C64 @default.
- Q64217297 P17 Q64217297-8B0B7BAD-3969-40AC-80BB-B9DE54CFC5B7 @default.
- Q64217297 P17 Q64217297-A3C025D2-F7AA-4EAB-A1ED-F7CD381CE116 @default.
- Q64217297 P17 Q64217297-A53C38FF-30D2-42BE-A79B-E07E7BAA37FF @default.
- Q64217297 P17 Q64217297-AB287004-62E4-42CB-AEC3-D0F38DFC935F @default.
- Q64217297 P17 Q64217297-B990857D-25E8-4914-9894-C2194035A5C8 @default.
- Q64217297 P17 Q64217297-E2A70C77-5180-47E1-9954-BA39C7C51EF2 @default.
- Q64217297 P17 Q64217297-E55AA9EB-0794-4BCB-BF8D-7A8D64E4A435 @default.
- Q64217297 P17 Q64217297-FEDFF540-1B7C-4240-80B6-B682A0A2C25A @default.
- Q64217297 P1813 Q64217297-A2DC0EF9-DD1E-4F84-95D1-46E534316CAA @default.
- Q64217297 P2899 Q64217297-06A336CE-436B-4C01-AE29-C0C68A8FF3F4 @default.
- Q64217297 P3098 Q64217297-F05E8A3B-4F87-481B-922C-78F8D4F9206A @default.
- Q64217297 P31 Q64217297-CBBA168C-A541-45FB-AD11-8BDCC7F33264 @default.
- Q64217297 P580 Q64217297-C3972FFA-C970-4358-B0DB-A90EBD19F554 @default.
- Q64217297 P582 Q64217297-ADE7D4D0-DF70-498B-8822-AEFD257A4C29 @default.
- Q64217297 P6099 Q64217297-BB8B14B5-13EB-4276-A7FB-098DBD944368 @default.
- Q64217297 P8363 Q64217297-0CA6A724-11B7-4C57-98F9-072B48AC7173 @default.
- Q64217297 P1132 "+530" @default.
- Q64217297 P1476 "An Open-label, Randomized Phase 3 Efficacy Study of ASP8273 vs Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations" @default.
- Q64217297 P17 Q142 @default.
- Q64217297 P17 Q145 @default.
- Q64217297 P17 Q16 @default.
- Q64217297 P17 Q17 @default.
- Q64217297 P17 Q183 @default.
- Q64217297 P17 Q212 @default.
- Q64217297 P17 Q218 @default.
- Q64217297 P17 Q28 @default.
- Q64217297 P17 Q29 @default.
- Q64217297 P17 Q298 @default.
- Q64217297 P17 Q30 @default.
- Q64217297 P17 Q31 @default.
- Q64217297 P17 Q334 @default.
- Q64217297 P17 Q38 @default.
- Q64217297 P17 Q408 @default.
- Q64217297 P17 Q419 @default.
- Q64217297 P17 Q45 @default.
- Q64217297 P17 Q55 @default.
- Q64217297 P17 Q833 @default.
- Q64217297 P17 Q865 @default.
- Q64217297 P17 Q869 @default.
- Q64217297 P1813 "SOLAR" @default.
- Q64217297 P2899 "+18" @default.
- Q64217297 P3098 "NCT02588261" @default.
- Q64217297 P31 Q30612 @default.
- Q64217297 P580 "2016-02-11T00:00:00Z" @default.
- Q64217297 P582 "2017-12-21T00:00:00Z" @default.
- Q64217297 P6099 Q42824827 @default.
- Q64217297 P8363 Q78089383 @default.